Clemex Technologies Inc. (TSXV:CXG.A)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Clemex Technologies Inc. Charts. Click Here for more Clemex Technologies Inc. Charts.](/p.php?pid=staticchart&s=TX%5ECXG.A&p=8&t=15)
MONTREAL, Aug. 12, 2011 /CNW/ --
Strong comeback to profitability and Sales increase by more than 43%
Symbol: CXG.A-TSX-V
www.clemex.com
Shares Outstanding: 20,749,810
MONTREAL, Aug. 12, 2011 /CNW Telbec/ - Clemex Technologies Inc. (TSXV:
CXG.A) announces its financial results for Fiscal Year ending April 30(th), 2011. The Corporation ends this Fiscal Year with a positive EBITDA of
$699 082 when compared to a negative EBITDA of $17 052 in 2010, et
ended the year with a Net Gain after taxes of $323,090 while a Net Loss
of $261,520 had been posted in 2010. Sales increased by 43.7% from
$3,659,129 in 2010 to $5,259,165 in 2011. The most significant increase
came from International sales which surpassed last year sales by 83.8%.
Gross margin slightly improved to 60.5% up from 59.3% last year.
When asked to comment these results, the President and CEO, Clement
Forget declared the following: "The upsurge of activity in the
industrial and manufacturing sectors which had begun at the end of 2010
Fiscal year has continued during this past year enabling the Company to
return to 2008 sales volume. This resumption in activity was
accompanied by renewed vigour in production rate and profitability
after two difficult years. We were able to end the year with a net
profit of $323,090 despite the severe fluctuations of the Canadian
dollar which also affects our profitability considering approximately
70% of our sales are concluded in US dollars."
Mr. Forget continued:" At about halfway into this Fiscal year, marketing
activities also resumed with renewed vigour given the rise in customer
demand and many opportunities in the market. The Company participated
in a greater number of trade shows, and its efforts generated results.
On the other hand, our research project of a medical device for
Hematology applications is moving along well and we should be setting
up our first functional prototype unit in a Montreal hospital this
coming fall. Finally, our distribution agreement with LEICA
Microsystems which began in March 2011 has not yet added to our sales
significantly but it will definitely contribute to increase our
business and visibility in Canada for years to come.
Financial Highlights
Fiscal year ended April 30(th), 2011 April 30(th), 2010
$ $
Sales 5, 259,165 3, 659,129
Gross Profit 3, 180,532 2, 169,141
60.5 % 59.3 %
Total Operating Expenses 2, 692,178 2, 398,628
EBITDA 699 082 (17 052)
Net Gain (Loss) &
Comprehensive
Income (Loss) 323,090 (261,520)
Basic gain (loss) Per Share 0.016 (0.013)
About Clemex Technologies, Inc.
Clemex Technologies Inc. develops, manufactures and markets image
analysis systems and software used by quality control and research
microscopy laboratories. Clemex customer base spans over many
countries in America, Europe, Asia and encompasses major Research and
Development Centers, prestigious Universities and large manufacturing
industries in various fields including healthcare, automotive,
aerospace, raw materials manufacturing, pharmaceuticals, mining and
other sectors.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy and accuracy of this news release.
To view this news release in HTML formatting, please use the following URL: http://www.cnw.ca/en/releases/archive/August2011/12/c3473.html
p bClemex Technologies Inc, /bbr/ 800 Guimond,br/ Longueuil, QC, Canada J4G 1T5,br/ br/ Contact:br/ br/ Clément Forgetbr/ Tel: 450.651.6573br/ Email: a href="mailto:ir@clemex.com" cr="true"ir@clemex.com/a /p